2012
DOI: 10.1016/j.actbio.2012.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Engineered silica nanocarriers as a high-payload delivery vehicle for antioxidant enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 64 publications
0
14
0
1
Order By: Relevance
“…In the past decade, mesoporous silica nanoparticles (MSNs) have shown significant advantages over traditional nanotransporters as in vivo delivery systems for exogenous molecules, due to their tailored mesoporous structure, high surface area, and excellent biocompatibility [20][21][22][23]. While the intracellular uptake of MSNs into mammalian cells has been widely studied, the investigation of their uptake by plant cells remains a relatively dormant field.…”
mentioning
confidence: 99%
“…In the past decade, mesoporous silica nanoparticles (MSNs) have shown significant advantages over traditional nanotransporters as in vivo delivery systems for exogenous molecules, due to their tailored mesoporous structure, high surface area, and excellent biocompatibility [20][21][22][23]. While the intracellular uptake of MSNs into mammalian cells has been widely studied, the investigation of their uptake by plant cells remains a relatively dormant field.…”
mentioning
confidence: 99%
“…2.5 ml of ammonium solution was dispersed into 40 ml of 0.32 M calcium nitrate solution under ultrasound irradiation (Ambati et al 2012, Poinern et al 2009). 60 ml of 0.19 M KH 2 PO 4 solution was added slowly with stirring while, maintaining pH 9 throughout the experiment lead to form white precipitate.…”
Section: Preparation Of Nanoceramic Core (Nc)mentioning
confidence: 99%
“…Intracellular protein delivery holds promise for a range of biomedical applications, [1] such as cancer therapy, [2,3] vaccination, and enzyme based therapeutics. [4] However, therapeutic proteins are susceptible to proteolysis and denaturation, limiting their efficacy in the body.…”
Section: Introductionmentioning
confidence: 99%
“…Also mesoporous silica nanoparticles (MSNs) have been studied as carriers for a variety of biomolecules including anticancer drugs, oligonucleotides, and proteins. [2,[12][13][14][15][16][17][18][19][20][21][22][23][24] However, most MSNs used in drug delivery studies to date typically have pores with diameters up to 4 nm, thereby limiting their use as efficient carriers for high the mesoporous silica nanoparticles (MSNs/cytC). The maximum cytC loading capacity of these cuboidal MSNs was determined to be 470 µg mg −1 MSNs (Figure 2a, black curve).…”
Section: Introductionmentioning
confidence: 99%